Find information on thousands of medical conditions and prescription drugs.

Deferoxamine

Deferoxamine, otherwise known as desferrioxamine or desferal, is a chelating agent used to remove excess iron from the body. It acts by binding free iron in the bloodstream and enhancing its elimination in the urine. By removing excess iron, the agent reduces the damage done to various organs and tissues, such as the liver. more...

Home
Diseases
Medicines
A
B
C
D
Dacarbazine
Dactinomycin
Dalmane
Danazol
Dantrolene
Dapoxetine
Dapsone
Daptomycin
Daraprim
Darvocet
Darvon
Daunorubicin
Daunorubicin
Daypro
DDAVP
Deca-Durabolin
Deferoxamine
Delsym
Demeclocycline
Demeclocycline
Demerol
Demulen
Denatonium
Depakene
Depakote
Depo-Provera
Desferal
Desflurane
Desipramine
Desmopressin
Desogen
Desogestrel
Desonide
Desoxyn
Desyrel
Detrol
Dexacort
Dexamethasone
Dexamfetamine
Dexedrine
Dexpanthenol
Dextran
Dextromethorphan
Dextromoramide
Dextropropoxyphene
Dextrorphan
Diabeta
Diacerein
Diacetolol
Dial
Diamox
Diazepam
Diazoxide
Dibenzepin
Diclofenac
Diclohexal
Didanosine
Dieldrin
Diethylcarbamazine
Diethylstilbestrol
Diethyltoluamide
Differin
Diflucan
Diflunisal
Digitoxin
Digoxin
Dihydrocodeine
Dihydroergotamine
Dihydrotachysterol
Dilantin
Dilaudid
Diltahexal
Diltiazem
Dimenhydrinate
Dimercaprol
Dimetapp
Dimethyl sulfoxide
Dimethyltryptamine
Dimetridazole
Diminazene
Diovan
Dioxybenzone
Diphenhydramine
Diphenoxylate
Dipipanone
Dipivefrine
Diprivan
Diprolene
Diproteverine
Dipyridamole
Disulfiram
Disulfiram
Dizocilpine
Dobutamine
Docetaxel
Docusate sodium
Dofetilide
Dolasetron
Dolobid
Dolophine
Domperidone
Donepezil
Dopamine
Dopram
Doral
Doramectin
Doriden
Dornase alfa
Doryx
Dostinex
Doxapram
Doxazosin
Doxepin
Doxil
Doxil
Doxorubicin
Doxy
Doxycycline
Doxyhexal
Doxylamine
Drisdol
Drixoral
Dronabinol
Droperidol
Drospirenone
Duloxetine
Durabolin
Duragesic
Duraphyl
Duraquin
Dutasteride
Dv
Dyclonine
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Deferoxamine is used to treat acute iron poisoning, especially in small children. Treatment with this agent is also frequently necessary in patients with certain types of chronic anemia (e.g. thalassemia and myelodysplastic syndrome) who require many blood transfusions, which can greatly increase the amount of iron in the body. Administration for chronic conditions is generally accomplished by subcutaneous injection (SQ) over a period of 8-12 hours daily. Administation of deferoxamine after acute intoxication may color the urine a pinkish red, a phenomenon termed "'vin rose urine".

Apart from in iron toxicity, deferoxamine is also used to treat aluminum toxicity (an excess of aluminum in the body) in certain patients.

Read more at Wikipedia.org


[List your site here Free!]


Antidotes
From OB/GYN News, 10/15/04 by Gerald G. Briggs

In nearly all cases of poisoning in which the health of a pregnant woman is in jeopardy and an antidote is needed, the woman's condition takes priority over the safety of the pregnancy and she should be treated the same as would a nonpregnant woman.

Only two antidotes--ethanol and penicillamine--pose a known risk to the embryo or fetus. But for most antidotes, the reported human pregnancy experience is typically limited to a few cases. For some, there is no human experience. The antidotes (targeted poisons shown in parentheses) are:

Naloxone, naltrexone, and nalmefene--a long-acting derivative of naltrexone with a plasma half-life of about 10 hours--are used to reverse narcotic overdose that is causing respiratory depression and/or marked sedation. All can be used in pregnancy.

Acetylcysteine (acetaminophen), used to prevent or lessen hepatic injury, is not teratogenic or embryotoxic in animals. Limited human pregnancy data suggest it is not toxic to the fetus. When administered intravenously, sufficient amounts cross the placenta to achieve protective serum levels in the fetus.

There are only two reports of IV digoxin immune Fab, ovine (digoxin) use in human pregnancy. Neither case involved a digoxin overdose.

Flumazenil (benzodiazepines) is not teratogenic or toxic to the embryo/fetus in animals at systemic exposures near those obtained in humans. It appears to cross the human placenta, and reverses the depressive effects of benzodiazepines in the fetus.

Fomepizole (ethylene glycol; methanol) was not teratogenic in mice studies, but only one case of human pregnancy exposure has been reported and the outcome was unknown. Shortterm use of ethanol also has been reported for poisonings with these two chemicals, but this use has not been studied in pregnancy. Neurotoxicity is a potential fetal complication.

There are five agents to treat heavy metal intoxication:

* Deferoxamine (acute and chronic iron) causes toxicity in two animal species, but human pregnancy experience is substantial, and no embryonic or fetal adverse effects attributable to the agent have been reported.

* Dimercaprol is either used alone (arsenic, gold, and acute mercury) or combined with edetate calcium disodium (lead). High doses are embryotoxic and teratogenic in mice. The published human pregnancy experience is limited to two arsenic and one lead poisoning cases, which both occurred after the first trimester. High levels of arsenic or lead were found in the newborns in two cases.

* Edetate calcium disodium (lead) is used either alone or in combination with dimercaprol. There are three reports of its use in human pregnancy, all late in gestation. A potential complication is maternal hypotension.

* Penicillamine is a chelating agent for copper in the treatment of Wilson's disease: there is one report of its use in mercury poisoning. First-trimester exposure is related to connective tissue anomalies (cutis laxa).

* Succimer (DSMA) (lead, arsenic, mercury, and cadmium) also chelates zinc. It is toxic and/or teratogenic in mice and rats, but some effects may have been due to zinc deficiency. Because of the absence of human pregnancy experience, other antidotes are preferable.

The reported human pregnancy experience with physostigmine (CNS effects of scopolamine, other anticholinergics, and tricyclic antidepressants) is limited to the last trimester. No adverse effects from the drug were seen.

Methylene blue (cyanide) is teratogenic and fetal toxic when given by intraamniotic injection in humans: its oral use as an antidote in pregnancy has not been reported. The effects of amyl nitrite, sodium nitrite, and sodium thiosulfate (the contents of the Cyanide Antidote Package) on human pregnancy also are unknown, as are the effects of high-dose hydroxocobalamin (cyanide).

Animal reproduction studies have not been conducted with commercially available antivenins for acute envenomations, and human reports are rare or completely absent.

Other antidotes include atropine (organophosphates and carbamates), calcium chloride or gluconate (calcium-channel-blocker, hydrofluoric acid), protamine (heparin), vitamin K (warfarin), folinic acid (methotrexate), and glucagon (hypoglycemia). The data for these agents do not suggest significant risk to the embryo or fetus.

Activated charcoal prevents absorption of substances from the gut and, if vomiting is prevented, presents no risk to the mother or her pregnancy. Similarly, syrup of ipecac, used to induce vomiting when indicated, is safe in pregnancy.

BY. GERALD G. BRIGGS, B. PHARM.

GERALD G. BRIGGS is pharmacist clinical specialist, Women's Hospital, Long Beach Memorial Medical Center; clinical professor of pharmacy, University of California, San Francisco; and adjunct professor of pharmacy, University of Southern California, Les Angeles. He is also coauthor of the reference book "Drugs in Pregnancy and Lactation."

COPYRIGHT 2004 International Medical News Group
COPYRIGHT 2004 Gale Group

Return to Deferoxamine
Home Contact Resources Exchange Links ebay